Harrison has a number of years’ experience in medical communications and market access consulting. He has conducted landscape assessments in cardiovascular disease, oncology, diabetes, and non-alcoholic steatohepatitis (NASH), incorporating targeted literature reviews and primary research to understand various stakeholder perspectives of the disease landscape, and to inform recommendations on market access strategy.
Additional projects have included development of value propositions, value message testing, and advisory board support.
Harrison holds a PhD in Cardiovascular Pharmacology from New College, University of Oxford.
Outside of work Harrison is a keen runner but most enjoys spending time with his young family.